Hoth Therapeutics, Inc. (HOTH) |
| 0.844 -0.054 (-5.97%) 07-13 15:59 |
| Open: | 0.838 |
| High: | 0.9 |
| Low: | 0.8188 |
| Volume: | 1,817,569 |
| Market Cap: | 11(M) |
| PE Ratio: | -1.05 |
| Exchange: | NASDAQ |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 2.35 |
| Resistance 1: | 1.74 |
| Pivot price: | 0.94 |
| Support 1: | 0.76 |
| Support 2: | 0.63 |
| 52w High: | 2.45 |
| 52w Low: | 0.4894 |
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Financials
| EPS | -0.800 |
| Book Value | 0.400 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -100.9 |
| Return on Equity (ttm) | -191.4 |
Company news
Thu, 28 May 2026
Hoth Therapeutics’ pivot to AI in space sees stock price rocket - Fierce Biotech
Wed, 27 May 2026
Hoth Therapeutics completes name change to Rocket One - Investing.com
Wed, 27 May 2026
Hoth Therapeutics Becomes Rocket One Inc. (Nasdaq: RKTO), Targeting the Space Economy with Next-Generation Nanomagnetic AI Chip Technology and Ultra-Low-Power, Radiation-Tolerant Computing for Space and Defense Applications - PR Newswire
Tue, 26 May 2026
Hoth Therapeutics Awarded U.S. Patent for Cancer-Fighting HT-KIT Oncology Platform - PR Newswire
Tue, 19 May 2026
AI Chip Energy Efficiency: Hoth Therapeutics Restructures as Rocket One Inc. to Enter the AI Semiconductor Infrastructure Market with Acquisition of Exclusive Rights to Next Generation AI Semiconductor Acceleration Technology Built on Non-Volatile Nanoma - PR Newswire
Tue, 19 May 2026
Hoth Therapeutics shares slide after shift toward AI semiconductor strategy (HOTH) - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
